The PAMCET Learning Team is the institutional curriculum and content group behind course publishing on this platform. PAMCET (Professional and Academic Management Centre for Education and Training) is operated by Digitpen Hub Ltd, a company registered in Lagos, Nigeria. Courses credited to the PAMCET Learning Team are structured, organized, and published centrally by the platform rather than authored by a single named individual instructor — each course's syllabus, learning outcomes, and content are reviewed before publication under this institutional account. For questions about a specific course or to report a content issue, please use the platform's Help & Support or Contact Us pages.
PHA 301: Systemic Pharmacology: Autonomic, Cardiovascular & Chemotherapeutic Agents (300 Level)
Therapeutic drug classes: ANS drugs, antihypertensives, antiarrhythmics, heart failure drugs, antimicrobials, antineoplastics, and immunosuppressants.
Course Overview
Therapeutic drug classes: ANS drugs, antihypertensives, antiarrhythmics, heart failure drugs, antimicrobials, antineoplastics, and immunosuppressants. Curriculum Structure & Core Modules: • 1. Autonomic Pharmacology: Cholinergic Agonists, Antagonists, Neuromuscular Blockers &...
What You'll Learn
- Explain the receptor mechanisms, hemodynamic effects, and indications of adrenergic and cholinergic agents.
- Rationalize combination pharmacotherapy in essential hypertension, heart failure, and ischemic heart disease.
- Compare classes of antibacterial drugs regarding mechanism of action, antimicrobial spectrum, and toxicities.
- Detail artemisinin-based combination therapies (ACTs) and second-line antimalarials in severe malaria.
- Describe the cellular mechanisms and dose-limiting toxicities of antineoplastic alkylating agents and antimetabolites.
Requirements
- Passing of 1st Professional MBBS Examination
- PHA 201 credit
Degree Programme Curriculum Context
This course is a curriculum unit of the Bachelor of Medicine, Bachelor of Surgery (MBBS) degree framework in Nigeria.
Earn Your Certificate
Showcase your skills with a certificate! Complete the course, submit your project, and earn your certificate. Here's a sample of what you'll receive to show off your accomplishments.

Course Curriculum
Browse complete theoretical foundations, worked calculations, laboratory protocols, and board assessment questions under each topic.
Autonomic Pharmacology: Cholinergic Agonists, Antagonists, Neuromuscular Blockers & Organophosphates: Structural Principles & Pathophysiological Derangements
PHA 301 • 300L • Pharmacology • Chapter 1 • Lecture 1 Autonomic Pharmacology: Cholinergic Agonists, Antagonists, Neuromuscular Blockers & Organophosphates: Structural Principles, Functional Architecture & Pathophysiological Derangements Curriculum Reference: PHA 301: Systemic Pharmacology: Autonomic, Cardiovascular & Chemotherapeutic Agents (300 Level) • Medical Ph...
Autonomic Pharmacology: Cholinergic Agonists, Antagonists, Neuromuscular Blockers & Organophosphates: Clinical Semiology, Differential Diagnosis & Evidence-Based Management
PHA 301 • 300L • Pharmacology • Chapter 1 • Lecture 2 Autonomic Pharmacology: Cholinergic Agonists, Antagonists, Neuromuscular Blockers & Organophosphates: Clinical Semiology, Differential Diagnosis & Evidence-Based Bedside Management Curriculum Reference: PHA 301: Systemic Pharmacology: Autonomic, Cardiovascular & Chemotherapeutic Agents (300 Level) • MDCN Profess...
Autonomic Pharmacology: Cholinergic Agonists, Antagonists, Neuromuscular Blockers & Organophosphates: Formative Clinical Case Assessment
Authentic clinical vignette self-assessment evaluating semiology, diagnostic decision-making, and therapeutics for Autonomic Pharmacology: Cholinergic Agonists, Antagonists, Neuromuscular Blockers & Organophosphates.
Adrenergic Pharmacology: Alpha/Beta Agonists, Antagonists & Clinical Vasopressors/Inotropes: Structural Principles & Pathophysiological Derangements
PHA 301 • 300L • Pharmacology • Chapter 2 • Lecture 1 Adrenergic Pharmacology: Alpha/Beta Agonists, Antagonists & Clinical Vasopressors/Inotropes: Structural Principles, Functional Architecture & Pathophysiological Derangements Curriculum Reference: PHA 301: Systemic Pharmacology: Autonomic, Cardiovascular & Chemotherapeutic Agents (300 Level) • Medical Pharmacolog...
Adrenergic Pharmacology: Alpha/Beta Agonists, Antagonists & Clinical Vasopressors/Inotropes: Clinical Semiology, Differential Diagnosis & Evidence-Based Management
PHA 301 • 300L • Pharmacology • Chapter 2 • Lecture 2 Adrenergic Pharmacology: Alpha/Beta Agonists, Antagonists & Clinical Vasopressors/Inotropes: Clinical Semiology, Differential Diagnosis & Evidence-Based Bedside Management Curriculum Reference: PHA 301: Systemic Pharmacology: Autonomic, Cardiovascular & Chemotherapeutic Agents (300 Level) • MDCN Professional MBB...
Adrenergic Pharmacology: Alpha/Beta Agonists, Antagonists & Clinical Vasopressors/Inotropes: Formative Clinical Case Assessment
Authentic clinical vignette self-assessment evaluating semiology, diagnostic decision-making, and therapeutics for Adrenergic Pharmacology: Alpha/Beta Agonists, Antagonists & Clinical Vasopressors/Inotropes.
Cardiovascular Drugs I: Antihypertensive Classes (ACEi, ARBs, CCBs, Thiazides, Central Agonists): Structural Principles & Pathophysiological Derangements
PHA 301 • 300L • Pharmacology • Chapter 3 • Lecture 1 Cardiovascular Drugs I: Antihypertensive Classes (ACEi, ARBs, CCBs, Thiazides, Central Agonists): Structural Principles, Functional Architecture & Pathophysiological Derangements Curriculum Reference: PHA 301: Systemic Pharmacology: Autonomic, Cardiovascular & Chemotherapeutic Agents (300 Level) • Medical Pharmacolo...
Cardiovascular Drugs I: Antihypertensive Classes (ACEi, ARBs, CCBs, Thiazides, Central Agonists): Clinical Semiology, Differential Diagnosis & Evidence-Based Management
PHA 301 • 300L • Pharmacology • Chapter 3 • Lecture 2 Cardiovascular Drugs I: Antihypertensive Classes (ACEi, ARBs, CCBs, Thiazides, Central Agonists): Clinical Semiology, Differential Diagnosis & Evidence-Based Bedside Management Curriculum Reference: PHA 301: Systemic Pharmacology: Autonomic, Cardiovascular & Chemotherapeutic Agents (300 Level) • MDCN Professional MB...
Cardiovascular Drugs I: Antihypertensive Classes (ACEi, ARBs, CCBs, Thiazides, Central Agonists): Formative Clinical Case Assessment
Authentic clinical vignette self-assessment evaluating semiology, diagnostic decision-making, and therapeutics for Cardiovascular Drugs I: Antihypertensive Classes (ACEi, ARBs, CCBs, Thiazides, Central Agonists).
Cardiovascular Drugs II: Antiarrhythmics (Vaughan-Williams), Anti-Anginals & Lipid-Lowering Statins: Structural Principles & Pathophysiological Derangements
PHA 301 • 300L • Pharmacology • Chapter 4 • Lecture 1 Cardiovascular Drugs II: Antiarrhythmics (Vaughan-Williams), Anti-Anginals & Lipid-Lowering Statins: Structural Principles, Functional Architecture & Pathophysiological Derangements Curriculum Reference: PHA 301: Systemic Pharmacology: Autonomic, Cardiovascular & Chemotherapeutic Agents (300 Level) • Medical Pha...
Cardiovascular Drugs II: Antiarrhythmics (Vaughan-Williams), Anti-Anginals & Lipid-Lowering Statins: Clinical Semiology, Differential Diagnosis & Evidence-Based Management
PHA 301 • 300L • Pharmacology • Chapter 4 • Lecture 2 Cardiovascular Drugs II: Antiarrhythmics (Vaughan-Williams), Anti-Anginals & Lipid-Lowering Statins: Clinical Semiology, Differential Diagnosis & Evidence-Based Bedside Management Curriculum Reference: PHA 301: Systemic Pharmacology: Autonomic, Cardiovascular & Chemotherapeutic Agents (300 Level) • MDCN Professi...
Cardiovascular Drugs II: Antiarrhythmics (Vaughan-Williams), Anti-Anginals & Lipid-Lowering Statins: Formative Clinical Case Assessment
Authentic clinical vignette self-assessment evaluating semiology, diagnostic decision-making, and therapeutics for Cardiovascular Drugs II: Antiarrhythmics (Vaughan-Williams), Anti-Anginals & Lipid-Lowering Statins.
Antimicrobial Chemotherapy I: Cell Wall Inhibitors (Penicillins, Cephalosporins, Carbapenems, Vancomycin): Structural Principles & Pathophysiological Derangements
PHA 301 • 300L • Pharmacology • Chapter 5 • Lecture 1 Antimicrobial Chemotherapy I: Cell Wall Inhibitors (Penicillins, Cephalosporins, Carbapenems, Vancomycin): Structural Principles, Functional Architecture & Pathophysiological Derangements Curriculum Reference: PHA 301: Systemic Pharmacology: Autonomic, Cardiovascular & Chemotherapeutic Agents (300 Level) • Medical P...
Antimicrobial Chemotherapy I: Cell Wall Inhibitors (Penicillins, Cephalosporins, Carbapenems, Vancomycin): Clinical Semiology, Differential Diagnosis & Evidence-Based Management
PHA 301 • 300L • Pharmacology • Chapter 5 • Lecture 2 Antimicrobial Chemotherapy I: Cell Wall Inhibitors (Penicillins, Cephalosporins, Carbapenems, Vancomycin): Clinical Semiology, Differential Diagnosis & Evidence-Based Bedside Management Curriculum Reference: PHA 301: Systemic Pharmacology: Autonomic, Cardiovascular & Chemotherapeutic Agents (300 Level) • MDCN Profes...
Antimicrobial Chemotherapy I: Cell Wall Inhibitors (Penicillins, Cephalosporins, Carbapenems, Vancomycin): Formative Clinical Case Assessment
Authentic clinical vignette self-assessment evaluating semiology, diagnostic decision-making, and therapeutics for Antimicrobial Chemotherapy I: Cell Wall Inhibitors (Penicillins, Cephalosporins, Carbapenems, Vancomycin).
Antimicrobial Chemotherapy II: Protein Synthesis Inhibitors (Aminoglycosides, Macrolides, Tetracyclines): Structural Principles & Pathophysiological Derangements
PHA 301 • 300L • Pharmacology • Chapter 6 • Lecture 1 Antimicrobial Chemotherapy II: Protein Synthesis Inhibitors (Aminoglycosides, Macrolides, Tetracyclines): Structural Principles, Functional Architecture & Pathophysiological Derangements Curriculum Reference: PHA 301: Systemic Pharmacology: Autonomic, Cardiovascular & Chemotherapeutic Agents (300 Level) • Medical Ph...
Antimicrobial Chemotherapy II: Protein Synthesis Inhibitors (Aminoglycosides, Macrolides, Tetracyclines): Clinical Semiology, Differential Diagnosis & Evidence-Based Management
PHA 301 • 300L • Pharmacology • Chapter 6 • Lecture 2 Antimicrobial Chemotherapy II: Protein Synthesis Inhibitors (Aminoglycosides, Macrolides, Tetracyclines): Clinical Semiology, Differential Diagnosis & Evidence-Based Bedside Management Curriculum Reference: PHA 301: Systemic Pharmacology: Autonomic, Cardiovascular & Chemotherapeutic Agents (300 Level) • MDCN Profess...
Antimicrobial Chemotherapy II: Protein Synthesis Inhibitors (Aminoglycosides, Macrolides, Tetracyclines): Formative Clinical Case Assessment
Authentic clinical vignette self-assessment evaluating semiology, diagnostic decision-making, and therapeutics for Antimicrobial Chemotherapy II: Protein Synthesis Inhibitors (Aminoglycosides, Macrolides, Tetracyclines).
Antiparasitic & Antiviral Drugs: ACTs, Anthelmintics, Antiretrovirals (ART) & Direct-Acting Antivirals: Structural Principles & Pathophysiological Derangements
PHA 301 • 300L • Pharmacology • Chapter 7 • Lecture 1 Antiparasitic & Antiviral Drugs: ACTs, Anthelmintics, Antiretrovirals (ART) & Direct-Acting Antivirals: Structural Principles, Functional Architecture & Pathophysiological Derangements Curriculum Reference: PHA 301: Systemic Pharmacology: Autonomic, Cardiovascular & Chemotherapeutic Agents (300 Level) • Medi...
Antiparasitic & Antiviral Drugs: ACTs, Anthelmintics, Antiretrovirals (ART) & Direct-Acting Antivirals: Clinical Semiology, Differential Diagnosis & Evidence-Based Management
PHA 301 • 300L • Pharmacology • Chapter 7 • Lecture 2 Antiparasitic & Antiviral Drugs: ACTs, Anthelmintics, Antiretrovirals (ART) & Direct-Acting Antivirals: Clinical Semiology, Differential Diagnosis & Evidence-Based Bedside Management Curriculum Reference: PHA 301: Systemic Pharmacology: Autonomic, Cardiovascular & Chemotherapeutic Agents (300 Level) • MDCN P...
Antiparasitic & Antiviral Drugs: ACTs, Anthelmintics, Antiretrovirals (ART) & Direct-Acting Antivirals: Formative Clinical Case Assessment
Authentic clinical vignette self-assessment evaluating semiology, diagnostic decision-making, and therapeutics for Antiparasitic & Antiviral Drugs: ACTs, Anthelmintics, Antiretrovirals (ART) & Direct-Acting Antivirals.
Chemotherapy of Neoplasms: Alkylating Agents, Antimetabolites, Cytotoxics & Monoclonal Antibodies: Structural Principles & Pathophysiological Derangements
PHA 301 • 300L • Pharmacology • Chapter 8 • Lecture 1 Chemotherapy of Neoplasms: Alkylating Agents, Antimetabolites, Cytotoxics & Monoclonal Antibodies: Structural Principles, Functional Architecture & Pathophysiological Derangements Curriculum Reference: PHA 301: Systemic Pharmacology: Autonomic, Cardiovascular & Chemotherapeutic Agents (300 Level) • Medical Pharm...
Chemotherapy of Neoplasms: Alkylating Agents, Antimetabolites, Cytotoxics & Monoclonal Antibodies: Clinical Semiology, Differential Diagnosis & Evidence-Based Management
PHA 301 • 300L • Pharmacology • Chapter 8 • Lecture 2 Chemotherapy of Neoplasms: Alkylating Agents, Antimetabolites, Cytotoxics & Monoclonal Antibodies: Clinical Semiology, Differential Diagnosis & Evidence-Based Bedside Management Curriculum Reference: PHA 301: Systemic Pharmacology: Autonomic, Cardiovascular & Chemotherapeutic Agents (300 Level) • MDCN Profession...
Chemotherapy of Neoplasms: Alkylating Agents, Antimetabolites, Cytotoxics & Monoclonal Antibodies: Formative Clinical Case Assessment
Authentic clinical vignette self-assessment evaluating semiology, diagnostic decision-making, and therapeutics for Chemotherapy of Neoplasms: Alkylating Agents, Antimetabolites, Cytotoxics & Monoclonal Antibodies.
Academic Ecosystem & Connected Pathways
Deepen your studies across connected learning pathways in the PAMCET academic network:
Instructor
PAMCET Learning Team
Institutional Course Curation · PAMCET
Qualifications:
PAMCET Learning Team — Institutional Course Curation, Digitpen Hub LtdMy Skills:
- Curriculum Curation
- Course Content Review
- Learning Outcome Design
- Course Publishing & Quality Assurance
- Platform Content Operations
Reviews
Course Includes
Download Syllabus & Study Guide
Receive the full lecture syllabus, reading list, and milestone schedule for PHA 301: Systemic Pharmacology: Autonomic, Cardiovascular & Chemotherapeutic Agents (300 Level).
By submitting, you agree to receive educational updates. You can unsubscribe anytime. Read our Privacy Policy.

